Latest debt-to-equity ratio
Travere Therapeutics Debt-to-equity ratio
Direct answer
Travere Therapeutics's debt-to-equity ratio is 2,515.72%.
The verified market snapshot reports 2,515.72%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2,515.72%
Explore related company data
View Travere Therapeutics's market capitalizationView Travere Therapeutics's price-to-book ratioView Travere Therapeutics's return on equityView Travere Therapeutics's dividend yieldView Travere Therapeutics's 52-week price rangeView Travere Therapeutics's revenue growthView Travere Therapeutics's profit marginView all Travere Therapeutics key metricsReturn to Travere Therapeutics profile